sumitomo pharma co ltd
-
Health News
Myovant Sciences rejects $2.5 bln takeover bid from Sumitovant, Sumitomo Pharma, Health News, ET HealthWorld
Myovant Sciences Ltd said on Sunday it rejected a $2.5 billion takeover offer from Sumitovant Biopharma and its parent group Sumitomo Pharma Co Ltd as…
Read More »